Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL

PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 16, 2024

Primary Completion Date

August 24, 2027

Study Completion Date

August 24, 2027

Conditions
Diffuse Large B-Cell Lymphoma
Interventions
DRUG

Acalabrutinib

Patients will receive acalabrutinib orally with dosing schedule of X.

BIOLOGICAL

Rituximab

Patients will receive rituximab via IV infusion on Cycle 1 Day 15 and via SC injection on Day 1 of Cycle 2 through Cycle 8.

Trial Locations (53)

16499

ACTIVE_NOT_RECRUITING

Research Site, Suwon

20705

RECRUITING

Research Site, Beltsville

21204

RECRUITING

Research Site, Towson

32256

ACTIVE_NOT_RECRUITING

Research Site, Jacksonville

40536

WITHDRAWN

Research Site, Lexington

42601

RECRUITING

Research Site, Daegu

44033

ACTIVE_NOT_RECRUITING

Research Site, Ulsan

47392

RECRUITING

Research Site, Busan

48202

ACTIVE_NOT_RECRUITING

Research Site, Detroit

49201

ACTIVE_NOT_RECRUITING

Research Site, Seogu

49241

RECRUITING

Research Site, Busan

50309

RECRUITING

Research Site, Des Moines

52727

ACTIVE_NOT_RECRUITING

Research Site, Gyeongsangnam-do

54907

RECRUITING

Research Site, Jeonju

57104

WITHDRAWN

Research Site, Sioux Falls

79410

RECRUITING

Research Site, Lubbock

92093

RECRUITING

Research Site, La Jolla

92868

RECRUITING

Research Site, Orange

94704

NOT_YET_RECRUITING

Research Site, Berkeley

98405

RECRUITING

Research Site, Tacoma

98506

ACTIVE_NOT_RECRUITING

Research Site, Olympia

1323000

RECRUITING

Research Site, São Paulo

06902

WITHDRAWN

Research Site, Stamford

14784-400

ACTIVE_NOT_RECRUITING

Research Site, Barretos

30150-221

ACTIVE_NOT_RECRUITING

Research Site, Belo Horizonte

70200-730

ACTIVE_NOT_RECRUITING

Research Site, Brasília

70390-700

RECRUITING

Research Site, Brasília

70840-901

ACTIVE_NOT_RECRUITING

Research Site, Brasília

13060-803

ACTIVE_NOT_RECRUITING

Research Site, Campinas

81520-060

ACTIVE_NOT_RECRUITING

Research Site, Curitiba

88020-210

RECRUITING

Research Site, Florianópolis

88034-000

RECRUITING

Research Site, Florianópolis

74605-020

ACTIVE_NOT_RECRUITING

Research Site, Goiânia

59075-740

ACTIVE_NOT_RECRUITING

Research Site, Natal

90035-003

ACTIVE_NOT_RECRUITING

Research Site, Porto Alegre

90880-480

ACTIVE_NOT_RECRUITING

Research Site, Porto Alegre

50070-480

ACTIVE_NOT_RECRUITING

Research Site, Recife

14048-900

RECRUITING

Research Site, Ribeirão Preto

20231-050

RECRUITING

Research Site, Rio de Janeiro

15090-000

RECRUITING

Research Site, São José do Rio Preto

65060-645

RECRUITING

Research Site, São Luís

01229-010

ACTIVE_NOT_RECRUITING

Research Site, São Paulo

01409-02

ACTIVE_NOT_RECRUITING

Research Site, São Paulo

05652-900

ACTIVE_NOT_RECRUITING

Research Site, São Paulo

08270-070

COMPLETED

Research Site, São Paulo

18030-005

ACTIVE_NOT_RECRUITING

Research Site, Sorocaba

00917

RECRUITING

Research Site, San Juan

405-760

RECRUITING

Research Site, Incheon

03722

RECRUITING

Research Site, Seoul

05505

ACTIVE_NOT_RECRUITING

Research Site, Seoul

06351

ACTIVE_NOT_RECRUITING

Research Site, Seoul

06591

RECRUITING

Research Site, Seoul

07985

ACTIVE_NOT_RECRUITING

Research Site, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY